Question
How monoclonal antibodies are typically produced using hybridoma technology?
Answer :
Word Count : 259
Monoclonal antibodies (mAbs) are produced using hybridoma technology, which involves the fusion of a specific antibody-producing B lymphocyte with a myeloma cell to create a hybrid cell line capable of indefinite growth and antibody production. The process begins with the immunization of a _______ ___ ______ ___ ___ ___ _______ ___.
____ ___ ________ _______ __________ _______ _____ _________ ________ _______ _________ ________.
__________ _____ _________ ______ _________ _________ _____ _________ _________ ______ ______.
______ ___ _____ ____ ___ ___ _________.
___ ______ ________ _______ __________ ___ _________ ____ ______ _________ ________ ____.
______ _____ _____ _____ ________ ___ ______ ______.
_______ _____ ____ _________ ______ _______.
_______ _______ __________ _______ ________ ________ ___.
________ _____ ________ ____ _______ ________ _________.
_____ ___ _________ ________ _________.
_________ ______ __________ ____ ____ ______ ____ _____ _________ _________ ______.
_______ ______ __________ _________ _______ ______.
______ _____ _______ ____ _____ ________.
____ ___ _______ _________ _____ ______ __________ ___.
__________ ____ _______ __________ _____ ______ _______ _________.
____ ______ ___ _______ ___ _____ _______.
_______ ___ _____ ______ ________ ___ _____ ___ _______ __________ ______.
_____ _________ _______ ____ ___ ________ ____ ___ _____.
____ _______ _________ ________ ______ ______.
___ _____ _______ _______ ______ ___ _____ _______ ____ _____ _________.
__________ _________ ______ _______ ____.
_____ __________ __________ __________ _____.
____ __________ ___ ________ _____.
____ ________ ____ ___ ____ ________ _________ ____ __________ ___.
______ _____ ________ _____ ________ ______ ___.
________ ________ _______ ____ _______ _________ ____ _________ ____ _______.
____ ____ ______ ___ _________ _________ __________ __________.
Get Full Answer on WhatsApp
Monoclonal antibodies (mAbs) are produced using hybridoma technology, which involves the fusion of a specific antibody-producing B lymphocyte with a myeloma cell to create a hybrid cell line capable of indefinite growth and antibody production. The process begins with the immunization of a _______ ___ ______ ___ ___ ___ _______ ___.
____ ___ ________ _______ __________ _______ _____ _________ ________ _______ _________ ________.
__________ _____ _________ ______ _________ _________ _____ _________ _________ ______ ______.
______ ___ _____ ____ ___ ___ _________.
___ ______ ________ _______ __________ ___ _________ ____ ______ _________ ________ ____.
______ _____ _____ _____ ________ ___ ______ ______.
_______ _____ ____ _________ ______ _______.
_______ _______ __________ _______ ________ ________ ___.
________ _____ ________ ____ _______ ________ _________.
_____ ___ _________ ________ _________.
_________ ______ __________ ____ ____ ______ ____ _____ _________ _________ ______.
_______ ______ __________ _________ _______ ______.
______ _____ _______ ____ _____ ________.
____ ___ _______ _________ _____ ______ __________ ___.
__________ ____ _______ __________ _____ ______ _______ _________.
____ ______ ___ _______ ___ _____ _______.
_______ ___ _____ ______ ________ ___ _____ ___ _______ __________ ______.
_____ _________ _______ ____ ___ ________ ____ ___ _____.
____ _______ _________ ________ ______ ______.
___ _____ _______ _______ ______ ___ _____ _______ ____ _____ _________.
__________ _________ ______ _______ ____.
_____ __________ __________ __________ _____.
____ __________ ___ ________ _____.
____ ________ ____ ___ ____ ________ _________ ____ __________ ___.
______ _____ ________ _____ ________ ______ ___.
________ ________ _______ ____ _______ _________ ____ _________ ____ _______.
____ ____ ______ ___ _________ _________ __________ __________.
Get Full Answer on WhatsApp
IGNOU NEWS
Assignment Submission Last Date Extended Till 30 June 2026 Click Here★★★IGNOU June 2026 TEE Date Sheet Released Click Here★★★